Pharma stocks are top sectoral gainers in trade

Published 31-01-2024, 08:12 pm
© Reuters.

New Delhi, Jan 31 (IANS) Pharma and healthcare stocks are top gainers on Wednesday with the index up 2.7 per cent.

BSE Healthcare index is the top gainer among all sectoral indices on Wednesday.

Sun Pharma (NS:SUN) is the top Sensex gainer with gains of more than 3 per cent. Dr Reddy’s is up more than 4 per cent. Max Healthcare (NS:MAXE) is up 6 per cent.

Gland Pharma (NS:GLAD) is up 6 per cent, Wockhardt (NS:WCKH) is up 4 per cent, Alembic Pharma is up 6 per cent.

The Fed decision tonight and the interim Budget tomorrow will weigh on markets in the near-term, says V K Vijayakumar, Chief Investment Strategist, Geojit Financial Services.

Global markets will be keenly watching the Fed comment on the timeline and quantum of rate cuts. The first rate cut is likely to come in June 2024. The decline in the 10-year yield to 4.02% is positive since it will restrain FPI outflows, he said.

The domestic market will be focused on the interim Budget particularly on any proposals regarding taxation of investments relating to the capital market. The fiscal deficit and its glide path also is important since growth with stability is hugely important from the market perspective, he said.

Stock specific movements are likely in response to sectoral allocations in the Budget, he added.

(Sanjeev Sharma can be reached at Sanjeev.s@ians.in)

--IANS

biz/san/uk

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.